Estudios originales

Published on 11 de noviembre de 2024 | http://doi.org/10.5867/medwave.2024.10.2939

Preventive behaviors for COVID-19 in Chile: Lessons from a population follow-up for 2021 and 2022

Back to article
Bivariate analysis of preventive measures score, sociodemographic, and health factors, years 2021 and 2022, Chile.*.
Year 2021Year 2022
VariablenMedianIQRp-valuenMedianIQRp-value
City (n = 386)Coquimbo1841817 to 190.001841918 to 200.54
Talca2021917 to 202021918 to 20
Gender (n = 386)Male1261817 to 190.031261917 to 200.05
Female2601917 to 202601918 to 20
Health insurance (n = 365)Public Insurance3131817 to 200.573131918 to 200.18
Private Insurance521817 to 19.5522018 to 20
Age (n = 386)7 to 19421716 to 190.00421816 to 190.00
20 to 29411716 to 18411817 to 20
30 to 491111918 to 201112018 to 20
50 to 59671917 to 20671918 to 20
60 and above1251917 to 201251918 to 20
Ethnicity (n = 386)No3601917 to 200.103601918 to 200.56
Yes261816 to 19261917 to 20
Education at age 18 or older (n = 351)Elementary and lower521918 to 200.57521918 to 200.38
Secondary1871817 to 201871918 to 20
Technical3418,518 to 20342018 to 20
Professional781917 to 20781918 to 20
In-person work (n = 386)No991917 to 200.301951918 to 200.03
Yes2871817 to 201911917 to 20
Healthcare worker (2021, n = 287; 2022, n = 191)No2821817 to 200.161791917 to 200.75
Yes51919 to 201219,518 to 20
Episodes of illness (n = 386)No2371817 to 200.802091918 to 200.09
Yes1491817 to 191771918 to 20
Number of episodes (2021, n = 149; 2022, n = 177)1981817 to 200.44841918 to 200.99
2 or more511918 to 20931918 to 20
COVID diagnosis (n = 386)No3511917 to 200.282981918 to 200.67
Yes351817 to 19881918 to 20
Symptomatology (n = 386)No3201917 to 200.242111918 to 200.13
Yes661817 to 191751918 to 20
Body mass index (n = 341; (underweight not included)
Normal951816 to 200.06951918 to 200.45
Overweight/obesity2461917 to 202461918 to 20
Comorbidity (n = 386)No1861817 to 190.101531917 to 200.04
Yes2001917 to 202332018 to 20
Tobacco (n = 386)No2831917 to 200.242831918 to 200.41
Yes1031817 to 201031917 to 20
Vaccine dosage (n = 386)No131817 to 190.0062020 to 200.00
Basal scheme (1 or 2 doses)1911817 to 19281817 to 19
Basal scheme + 1 boosters1821918 to 202131918 to 20
Basal scheme + 2 booster1392018 to 20

IQR, interquartile range.

*All responses availables were considered for each category and year.

Source: Prepared by the authors based on the results of the study.